Insomnia in older adults: A review of treatment options.

Roberto León-Barriera, Margaret M Chaplin, Jasleen Kaur, Vania Modesto-Lowe

Review Cleveland Clinic journal of medicine 2025 12 цитирований

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D39746731'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

Тип исследования: review

Вмешательство: Insomnia in older adults: A review of treatment options. various
Препарат сравнения: Placebo
Направление эффекта: Positive
Риск систематической ошибки: Moderate

Abstract

Insomnia is a common and challenging complaint in older adults (> 65 years) because of age-related alterations in sleep physiology. Cognitive behavioral therapy for insomnia is the gold standard for treatment of insomnia in young as well as older patients. Both clinicians and patients often prefer the simplicity of medication, but risks associated with some hypnotics increase with age. Pharmacologic options for older adults include low-dose doxepin, melatonin, ramelteon, and the dual orexin receptor antagonists. A well-informed clinician can help patients navigate the risks and benefits of both pharmacologic and behavioral options.

Used In Evidence Reviews

A Melatonin для Бессонница

Insomnia in older adults: A review of treatment options.

Embed This Widget

Study Design

Abstract

Used In Evidence Reviews

Similar Papers

European guideline for the diagnosis and treatment of insomnia.

Circadian typology: a comprehensive review.

Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Regulation of terminal differentiation of cultured human keratinocytes by vitamin A.

Role of melatonin in the regulation of human circadian rhythms and sleep.